Since September 2014 I am director of the Institute of Medical Microbiology at the RWTH University Hospital. The institute actively participates in the education of medical students and the graduate and postgraduate education of life science students. Is additionally involved in research on the epidemiology, pathogenesis and immune response to infectious diseases. Our main reseach interests are epidemiological studies on streptococcal diseases performed by the National Reference Laboratory (NRZ) on Streptococcal Diseases, novel strategies of antiinfectious therapies (antimicrobial peptides and phages), studies on the mucosal antimicrobial host defense mainly against enteropathogenic viruses, parasites and bacteria as well as functional investigations on the role of the enteric microbiota. You can find information on our work, the team members and research activities on the following pages.
Mathias Hornef, M.D.
Professor for Medical Microbiology
A new family of gut bacteria described
The Clavel lab with other colleagues in Germany report in the February edition of Microbiome the characterization of the family Muribaculaceae, which includes many prevalent and dominant bacterial...
Host-microbiota interaction study funded by the German Research Foundation (DFG)
The German Research Foundation funds a cooperative project between Oliver Pabst (Institute of Molecular Medicine), Tom Clavel, Hans-Peter Horz and Mathias Hornef (Institute of Medical Microbiology)...